<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-28T15:40:45Z</responseDate><request verb="GetRecord" identifier="oai:riubu.ubu.es:10259/8634" metadataPrefix="oai_dc">https://riubu.ubu.es/oai/request</request><GetRecord><record><header><identifier>oai:riubu.ubu.es:10259/8634</identifier><datestamp>2025-01-22T10:15:49Z</datestamp><setSpec>com_10259_9895</setSpec><setSpec>com_10259_3989</setSpec><setSpec>com_10259.4_106</setSpec><setSpec>com_10259_2604</setSpec><setSpec>col_10259_9896</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>Postnatal exposure to low doses of Chlorpyrifos induces long-term effects on 5C-SRTT learning and performance, cholinergic and GABAergic systems and BDNF expression</dc:title>
<dc:creator>Pérez Fernández, Cristian</dc:creator>
<dc:creator>Morales Navas, Miguel</dc:creator>
<dc:creator>Guardia Escote, Laia</dc:creator>
<dc:creator>Colomina, María Teresa</dc:creator>
<dc:creator>Giménez, Estela</dc:creator>
<dc:creator>Sánchez Santed, Fernando</dc:creator>
<dc:subject>Chlorpyrifos</dc:subject>
<dc:subject>Locomotor activity</dc:subject>
<dc:subject>Learning</dc:subject>
<dc:subject>Attention</dc:subject>
<dc:subject>Inhibitory control</dc:subject>
<dc:subject>Brain-derived neurotrophic factor</dc:subject>
<dc:subject>Fisiología</dc:subject>
<dc:subject>Biología molecular</dc:subject>
<dc:subject>Sistema nervioso-Enfermedades</dc:subject>
<dc:subject>Physiology</dc:subject>
<dc:subject>Molecular biology</dc:subject>
<dc:subject>Nervous system-Diseases</dc:subject>
<dc:description>Alterations in attention and inhibitory control are common features in several neurological disorders.&#xd;
Environmental factors such as exposure to pesticides have been linked to their appearance. Chlorpyrifos (CPF) is&#xd;
one of the most widely used organophosphate compounds in the world. CPF exposure during development seems&#xd;
to be critical for later behavioral and molecular disruptions during adult ages, although this depends on the&#xd;
specific period of development, where the preweaning period is one of the least studied. Despite the abundant&#xd;
empirical work made in the last decades on developmental CPF exposure, the systematic study of this on attention is sparse, and nonexistent concerning inhibitory control, without a single study on preweaning developmental stages. The present research explored the effects of the exposure to low doses of CPF that do not elicit a&#xd;
significant inhibition of the Cholinesterases during this developmental period on rats' behavior in the five-choice&#xd;
serial reaction time task. Behavioral manipulations (inter-trial interval and stimulus duration), pharmacological&#xd;
manipulations (cholinergic and GABAergic drugs) and brain gene expression analyses were also conducted.&#xd;
Exposure to CPF decreased the locomotor activity and enhanced the learning profile of the female rats, increased&#xd;
the impulsive rates, unmasked by a longer inter-trial interval, hypo-sensitized the cholinergic system and downregulated the mRNA expression levels of the brain-derived neurotrophic factor in the dorsal striatum of the male&#xd;
rats. This happened without significant inhibition of the brain Acetylcholinesterase. All this new information&#xd;
corroborates that the exposure to a common pesticide at low doses during a key, but under-explored developmental period importantly affects different behaviors, neurotransmitter systems, and molecules that are altered&#xd;
in the main neurological disorders observed nowadays.</dc:description>
<dc:description>The present study was supported by two grants from the Ministerio de Economía y Competitividad, Spanish Government and the Fondo Europeo de Desarrollo Regional (MINECO-FEDER). Grant numbers: PSI2017-86847-C2-1-R MINECO-FEDER and PSI2017-86847-C2-2-R.</dc:description>
<dc:date>2024-02-08T11:52:31Z</dc:date>
<dc:date>2024-02-08T11:52:31Z</dc:date>
<dc:date>2020-08</dc:date>
<dc:type>info:eu-repo/semantics/article</dc:type>
<dc:type>info:eu-repo/semantics/acceptedVersion</dc:type>
<dc:identifier>0014-4886</dc:identifier>
<dc:identifier>http://hdl.handle.net/10259/8634</dc:identifier>
<dc:identifier>10.1016/j.expneurol.2020.113356</dc:identifier>
<dc:language>eng</dc:language>
<dc:relation>Experimental Neurology. 2020, V. 330, 113356</dc:relation>
<dc:relation>https://doi.org/10.1016/j.expneurol.2020.113356</dc:relation>
<dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 Internacional</dc:rights>
<dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
<dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
<dc:format>application/pdf</dc:format>
<dc:publisher>Elsevier</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>